DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Meridia (Sibutramine Hydrochloride) - Current Clinical Trials

 
 



Meridia Related Clinical Trials

Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited Genes [Completed]

Effects of Clopidogrel and Clarithromycin on the Oral Disposition of Sibutramine in Healthy Subjects [Completed]

A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients [Completed]

Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese Patients [Active, not recruiting]

Studying the Effects of Sibutramine on Eating Behavior [Terminated]

Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese Hypertensives [Completed]

Treatment of Binge Eating in Obese Patients in Primary Care [Completed]

A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects. [Completed]

Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects [Terminated]

Assess the Additional Weight Loss Effect of Orlistat Used in Combination With Sibutramine [Completed]

A Functional Magnetic Resonance Imaging (fMRI) Study in Overweight and Obese Men (0000-103) [Completed]

Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population [Completed]

"Efficacy in Adolescents of Continued Behavior Modification Following a Six Month Sibutramine-based Weight Management Intervention" [Recruiting]

A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety. [Completed]

A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects [Completed]

Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates [Completed]

Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) Patients [Completed]

A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder [Completed]

Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS [Completed]

Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity [Completed]

The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS) [Active, not recruiting]

A Weight Loss Study in Overweight Men and Women [Terminated]

A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects [Completed]

A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese Subjects [Completed]

Adolescent Weight Management Study [Completed]

Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED) [Completed]

Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care [Active, not recruiting]

A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects [Completed]

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder [Completed]

LOSS- Louisiana Obese Subjects Study [Terminated]

Effects of Weight Loss in Obese Difficult-to-treat Asthmatics [Completed]

Comparative Study of Intragastric Balloon and Pharmacotherapy for Non-Morbid Obesity [Recruiting]

Study of Five Different Methods Of Delivering A Lifestyle Modification Program for Weight Loss [Completed]

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. [Completed]

Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer [Completed]

Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer [Completed]

Chromium Piccolinate in the Prevention of Weight Gain Induced by Serotonergic Medications Initiated on Psychiatric Inpatient Units. [Terminated]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017